SEARCH

SEARCH BY CITATION

References

  • 1
    D'Amico G, Pasta L, Madonia S, Tarantino G, Mancuso A, Malizia G, et al. The incidence of esophageal varices in cirrhosis. Gastroenterology 2001; 120: A2.
  • 2
    De Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005; 43: 167176.
  • 3
    Garcia-Tsao G. Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Gastroenterology 2001; 120: 726748.
  • 4
    Grace ND. Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. American College of Gastroenterology Practice Parameters Committee. Am J Gastroenterol 1997; 92: 10811091.
  • 5
    Grace ND, Groszmann RJ, Garcia-Tsao G, Burroughs AK, Pagliaro L, Makuch RW, et al. Portal hypertension and variceal bleeding: an AASLD single topic symposium. HEPATOLOGY 1998; 28: 868880.
  • 6
    Qureshi W, Adler DG, Davila R, Egan J, Hirota W, Leighton J, et al. ASGE guideline: the role of endoscopy in the management of variceal hemorrhage, updated July 2005. Gastrointest Endosc 2005; 62: 651655.
  • 7
    Renner E. WGO-OMGE practice guideline: treatment of esophageal varices. Available at: www.omgc.org/globalguidelines/guide08.html. Accessed on May 2003.
  • 8
    D'Amico G, Morabito A. Noninvasive markers of esophageal varices: another round, not the last. HEPATOLOGY 2004; 39: 3034.
  • 9
    Groszmann RJ, Garcia-Tsao G, Bosch J, Grace ND, Burroughs AK, Planas R, et al., for the Portal Hypertension Collaborative Group. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med 2005; 353: 22542261.
  • 10
    Garcia-Tsao G, D'Amico G, Abraldes JG, Schepis F, Merli M, Kim WR, et al. Predictive models in portal hypertension. In: de FranchisR, ed. Portal Hypertension IV: Proceedings of the Fourth Baveno International Consensus Workshop on Methodology of Diagnosis and Treatment. Oxford, UK: Blackwell Publishing; 2006: 47102.
  • 11
    Bashour FN, Teran JC, Mullen KD. Prevalence of peripheral blood cytopenias (hypersplenism) in patients with nonalcoholic chronic liver disease. Am J Gastroenterol 2000; 95: 29362939.
    Direct Link:
  • 12
    Peck-Radosavljevic M. Hypersplenism. Eur J Gastroenterol Hepatol 2001; 13: 317323.
  • 13
    Peck-Radosavljevic M. Thrombocytopenia in liver disease. Can J Gastroenterol 2000; 14(Suppl D): D60D66.
  • 14
    Zein CO, Lindor KD, Angulo P. Prevalence and predictors of esophageal varices in patients with primary sclerosing cholangitis. HEPATOLOGY 2004; 39: 204210.
  • 15
    Pilette C, Oberti F, Aube C, Rousselet MC, Bedossa P, Gallois Y, et al. Non-invasive diagnosis of esophageal varices in chronic liver diseases. J Hepatol 1999; 31: 867873.
  • 16
    Zaman A, Hapke R, Flora K, Rosen HR, Benner K. Factors predicting the presence of esophageal or gastric varices in patients with advanced liver disease. Am J Gastroenterol 1999; 94: 32923296.
    Direct Link:
  • 17
    Madhotra R, Mulcahy HE, Willner I, Reuben A. Prediction of esophageal varices in patients with cirrhosis. J Clin Gastroenterol 2002; 34: 8185.
  • 18
    Sanyal AJ, Fontana RJ, Di Bisceglie AM, Everhart JE, Doherty MC, Everson GT, et al., and the HALT-C Trial Group. The prevalence and risk factors associated with esophageal varices in subjects with hepatitis C and advanced fibrosis. Gastrointest Endosc 2006; 64: 855864.
  • 19
    Groszmann RJ, Wongcharatrawee S. The hepatic venous pressure gradient: anything worth doing should be done right. HEPATOLOGY 2004; 39: 280283.
  • 20
    Arguedas MR, McGuire BM, Fallon MB, Abrams GA. The use of screening and preventive therapies for gastroesophageal varices in patients referred for evaluation of orthotopic liver transplantation. Am J Gastroenterol 2001; 96: 833837.
    Direct Link:
  • 21
    Zaman A, Hapke RJ, Flora K, Rosen HR, Benner KG. Changing compliance to the American College of Gastroenterology guidelines for the management of variceal hemorrhage: a regional survey. Am J Gastroenterol 2004; 99: 645649.
    Direct Link:
  • 22
    Giannini EG, Zaman A, Kreil A, Floreani A, Dulbecco P, Testa E, et al. Platelet count/spleen diameter ratio of esophageal varices: results of a multicenter, prospective, validation study. Am J Gastroenterol 2006; 101: 25112519.
  • 23
    Ripoll C, Groszmann RJ, Garcia-Tsao G, Grace ND, Burroughs A, Planas R, et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology 2007; 133: 481488.
  • 24
    Ripoll C, Groszmann RJ, Garcia-Tsao G, Grace ND, Burroughs A, Planas R, et al. Hepatic venous pressure gradient predicts the development of hepatocellular carcinoma independent of duration and severity of cirrhosis [Abstract]. HEPATOLOGY 2006; 44(Suppl): 152.
  • 25
    Dittrich S, de Mattos AA, Cheinquer H, de Araujo FB. Correlation between platelet blood levels and the hepatic venous pressure gradient among patients with cirrhosis. Arq Gastroenterol 2005; 42: 3540.